僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Spartalizumab （PDR001） is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma （ATC）